Labomar Logo

Labomar

A full-service CDMO for supplements, medical devices, and dermo-cosmetic products.

LBM | XMIL

Overview

Corporate Details

ISIN(s):
IT0005421646
LEI:
815600BD66DA7878FF03
Country:
Italy
Address:
VIA NAZARIO SAURO, 35/I, 31036 ISTRANA

Description

Labomar is a Contract Development and Manufacturing Organization (CDMO) that specializes in creating and producing food supplements, medical devices, foods for special medical purposes (FSMPs), and dermo-cosmetic products. The company operates as a full-service, one-stop-shop partner, offering customized development of bespoke products and ready-to-market formulations. Labomar leverages patented and advanced technologies with a strong emphasis on scientific research and innovation to manufacture high-quality products. Its services cover the entire product lifecycle, from formulation and the production of plant extracts to manufacturing and regulatory support for its clients.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-09-06 14:28
Comunicato Procedura congiunta e revoca
Italian 282.1 KB
2023-08-31 19:53
Comunicato ex art. 41, comma 2, lett. c) RE
Italian 282.5 KB
2023-08-29 17:19
Comunicato Risultati Definitivi Sell-Out
Italian 300.3 KB
2023-08-28 17:56
Comunicato Risultati Provvisori Sell-Out
Italian 301.7 KB
2023-08-25 17:56
Comunicato adesioni Sell-Out terza settimana
Italian 302.1 KB
2023-08-18 18:16
Comunicato Adesioni Sell Out Seconda Settimana
Italian 300.8 KB
2023-08-11 18:04
Comunicato adesioni Sell-Out prima settimana
Italian 303.6 KB
2023-08-04 23:17
Comunicato ex art. 41, comma 2, lett. c) RE
Italian 687.4 KB
2023-08-04 20:09
Comunicato Azionista Significativo LBM Next S.p.A.
Italian 398.1 KB
2023-08-04 20:07
Comunicato Azionista Significativo_conferimento LBM Holding
Italian 397.5 KB
2023-08-04 20:06
Comunicato Azionista Significativo_Master Lab
Italian 398.3 KB
2023-08-04 20:03
Comunicato Azionista Significativo_CCP
Italian 396.9 KB
2023-08-02 19:34
Comunicato risultati OPA definitivi
Italian 783.8 KB
2023-08-01 18:07
Comunicato ex art. 41, comma 2, lett. c) RE
Italian 285.3 KB
2023-07-31 18:53
Comunicato risultati OPA provvisori
Italian 308.4 KB

Automate Your Workflow. Get a real-time feed of all Labomar filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Labomar

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Labomar via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ABEONA THERAPEUTICS INC. Logo
A clinical-stage biopharma developing cell and gene therapies for rare diseases.
United States of America
ABEO
ABINGDON HEALTH PLC Logo
A CDMO specializing in lateral flow assays, offering development to manufacturing services.
United Kingdom
ABDX
ABIONYX Pharma Logo
Develops biotherapies and drug delivery vectors using apolipoprotein A-I.
France
ABNX
ABIVAX Logo
Clinical-stage biotech developing therapeutics for chronic inflammatory diseases.
France
ABVX
Abivax S.A. Logo
Clinical-stage biotech developing miRNA therapeutics for inflammatory diseases.
United States of America
ABVX
ABL Diagnostics Logo
Develops molecular diagnostic solutions for managing infectious diseases.
France
ABLD
Abliva Logo
Biopharmaceutical company developing medicines for primary mitochondrial diseases.
Sweden
ABLI
AB Science Logo
Researches and develops protein kinase inhibitors for human and veterinary medicine.
France
AB
ABVC BIOPHARMA, INC. Logo
Develops botanical drugs and medical devices for oncology, ophthalmology, and CNS.
United States of America
ABVC
ACADIA PHARMACEUTICALS INC Logo
Biopharmaceutical company developing medicines for CNS disorders and rare diseases.
United States of America
ACAD

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.